Please log in to see the full text of this API!

Amlodipine

  • ATC: C08CA01
  • Use: Lorem  Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:408.88 g/mol
  • CAS-RN:88150-42-9
  • InChI Key:HTIQEAQVCYTUBX-UHFFFAOYSA-N
  • InChI:InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3

Derivatives

    maleate (1:1)

  • Formula: C20H25ClN2O5 • C4H4O4
  • MW:524.95 g/mol
  • CAS-RN:88150-47-4

    besylate (benzenesulfonate)

  • Formula: C20H25ClN2O5 • C6H6O3S
  • MW:567.06 g/mol
  • CAS-RN:111470-99-6

Substance Classes

Synthesis Path








Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
1517-05-1 C2H5N3O 2-azidoethanol Ethanol, 2-azido-
89-98-5 C7H5ClO o-chlorobenzaldehyde Benzaldehyde, 2-chloro-
88150-45-2 C8H13N3O4 ethyl 4-(2-azidoethoxy)acetoacetate Butanoic acid, 4-(2-azidoethoxy)-3-oxo-, ethyl ester
638-07-3 C6H9ClO3 ethyl 4-chloroacetoacetate Butanoic acid, 4-chloro-3-oxo-, ethyl ester
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
D Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem Lorem
Lorem ipsum Lorem
Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem ipsum dolor
F Lorem Lorem
Lorem Lorem comb.
Lorem Lorem
GB Lorem Lorem
Lorem Lorem
I Lorem Lorem ,1991
Lorem Lorem ,1991
Lorem Lorem
J Lorem Lorem Lorem
Lorem Lorem
USA Lorem Lorem
Lorem Lorem
Lorem Lorem ,1991
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinvidunt

References

    • US 9 999 999 (Pfizer; 25.2.1986; GB-prior. 11.3.1982).
    • EP 99 999 (Pfizer; appl. 8.3.1983; GB-prior. 11.3.1982).
    • EP 999 999 (Lek; appl. 19.11.1993; SI-prior. 26.11.1992).
    • CA 9 999 999 (Apotex; appl. 17.10.1996; NZ-prior. 1.11.1995).
  • besylate salt:

    • EP 999 999 (Pfizer; appl. 31.3.1987; GB-prior. 4.4.1986).
    • US 9 999 999 (Pfizer; 7.11.1989; GB-prior. 4.4.1986).
  • racemate resolution:

    • Arrowsmith, J.E. et al.: J. Med. Chem. (JMCMAR) 29, 1696 (1986).
    • EP 999 999 (Pfizer; appl. 16.2.1989; GB-prior. 27.2.1988).
  • combination with ACE-inhibitors:

    • WO 9 999 999 (Pfizer; appl. 26.2.1996; USA-prior. 16.3.1995).